Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
902.15
10.60 (1.19%) Cadila Healthcare - Quaterly Results
Date: 03-02-2022
The revenue for the December 2021 quarter is pegged at Rs. 18303.00 millions against Rs. 19188.00 millions recorded during the year-ago period.A comparatively good net profit growth of 40.41% to Rs. 1970.00 millions was reported for the quarter ended December 2021 compared to Rs. 1403.00 millions of previous same quarter.The Operating Profit of the company witnessed a decrease to 3845.00 millions from 5231.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 18303.00 | 19188.00 | -4.61 | 59626.00 | 57716.00 | 3.31 | 77904.00 | 63474.00 | 22.73 |
| Other Income | 259.00 | 250.00 | 3.60 | 1250.00 | 1058.00 | 18.15 | 789.00 | 8494.00 | -90.71 |
| PBIDT | 3845.00 | 5231.00 | -26.50 | 15855.00 | 18207.00 | -12.92 | 23980.00 | 22725.00 | 5.52 |
| Interest | 246.00 | 156.00 | 57.69 | 929.00 | 504.00 | 84.33 | 709.00 | 2339.00 | -69.69 |
| PBDT | 3599.00 | 3200.00 | 12.47 | 11733.00 | 15828.00 | -25.87 | 21396.00 | 19866.00 | 7.70 |
| Depreciation | 1200.00 | 1131.00 | 6.10 | 3559.00 | 3361.00 | 5.89 | 4511.00 | 4289.00 | 5.18 |
| PBT | 2399.00 | 2069.00 | 15.95 | 8174.00 | 12467.00 | -34.43 | 16885.00 | 15577.00 | 8.40 |
| TAX | 429.00 | 666.00 | -35.59 | 2064.00 | 2352.00 | -12.24 | 2123.00 | 2041.00 | 4.02 |
| Deferred Tax | 183.00 | 24.00 | 662.50 | 241.00 | -126.00 | -291.27 | -910.00 | 400.00 | -327.50 |
| PAT | 1970.00 | 1403.00 | 40.41 | 6110.00 | 10115.00 | -39.59 | 14762.00 | 13536.00 | 9.06 |
| Equity | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 |
| PBIDTM(%) | 21.01 | 27.26 | -22.94 | 26.59 | 31.55 | -15.71 | 30.78 | 35.80 | -14.02 |